Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes for at least 24 months~* BMI between 18 and 30 kg/m2~* Insulin naive subjects~* OAD treatment with max two OADs alone or combined with other therapy~* HbA1c between 7-12%~Exclusion Criteria:~* Type 1 diabetes~* Receipt of any investigational drug within the last three months prior to this trial~* Current or previous treatment with thiazolidiones within the last 6 months~* OAD treatment with three or more OADs within the last 4 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).